SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001144204-13-069072
Filing Date
2013-12-26
Accepted
2013-12-26 14:17:22
Documents
1
Group Members
AUGUSTINE LAWLORCHRISTOPHER MIRABELLI, PH.D.HAROLD R. WERNERHEALTHCARE PARTNERS VII, L.P.JAMES H. CAVANAUGH, PH.D.JOHN W. LITTLECHILD

Document Format Files

Seq Description Document Type Size
1 SC 13D v363937_sc13d.htm SC 13D 147493
  Complete submission text file 0001144204-13-069072.txt   149212
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 301 CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 301 CAMBRIDGE MA 02142 609-430-3900
HEALTHCARE VENTURES VII LP (Filed by) CIK: 0001202615 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 343 PHOENIXVILLE PIKE MALVERN PA 19355
Business Address 343 PHOENIXVILLE PIKE MALVERN PA 19355 610-889-9900
TETRALOGIC PHARMACEUTICALS CORP (Subject) CIK: 0001361248 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87773 | Film No.: 131298449
SIC: 2834 Pharmaceutical Preparations